Research
The 16th annual ALS Network Research Summit (formerly the California ALS Research Summit) brought together over 200 researchers, clinicians, biotech representatives, government officials, partner organizations, and advocates in ALS and…
Three Days of Science, Translation, and Momentum The ALS Network Research Summit convened global leaders across academia, industry, and clinical care to accelerate progress toward effective treatments and cures. Across…
In the U.S., clinical trials for amyotrophic lateral sclerosis (ALS) do not include enough non-white patients and women to fully represent the disease’s landscape in the real world, a study found.
Born and raised in Dalian, China, Mark Ma grew up in an environment where he often felt unable to speak freely. As a tall and physically different child, he was…
MDA’s partnership in research includes collaborative research grants with the ALS Network, Cure ADSSL1, Coalition to Cure Calpain 3, Cure CMD, Friedreich’s Ataxia Research Alliance, The Myositis Association, and United…
11/20/25 – FOR IMMEDIATE RELEASE LOS ANGELES – The ALS Network, in partnership with 12 ALS United member organizations, announces the selection of its 2025 Research Innovation Grantees—an accomplished group…
DALLAS–(BUSINESS WIRE)–The Impossible Dream Machine, an initiative founded by Broadway actor, Grammy-nominated singer, and ALS patient and advocate Aaron Lazar, has announced a groundbreaking collaboration with the Parkland Center for…
Dr. Steve Finkbeiner and his team at the Gladstone Institutes have developed an AI-powered “thinking microscope” that can independently run experiments, learn from what it observes, and rapidly analyze data — far beyond…
In amyotrophic lateral sclerosis, or ALS, misfolded proteins in motor neurons cause progressive muscle weakness and paralysis. People with ALS often die within 2 to 4 years after symptoms start.…
Dear Friends, I am grateful for your steadfast support of the ALS Network and invite you to read our new Impact Report. We are excited to share how your partnership powers our mission-critical…